Showing results (191-200 of 206) with videos related to
Sort By:
Pageof 21
JAMA|January 5, 1990
Non-A, non-B hepatitis and antibody to hepatitis C virusJ W Mosley, R D Aach, F B Hollinger, et al.Pediatrics|August 1, 1991
Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disordersJ M Lusher, E A Operskalski, L M Aledort, et al.The New England Journal of Medicine|November 8, 1990
Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study GroupM P Busch, P E Taylor, B A Lenes, et al.The Journal of Infectious Diseases|February 1, 1997
Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation centerH E Vargas, L F Wang, T Laskus, et al.Digestive Diseases and Sciences|April 1, 1993
Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgMD D Douglas, J Rakela, H J Lin, et al.Hepatology (Baltimore, Md.)|April 27, 1999
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant GroupR Perrillo, J Rakela, J Dienstag, et al.Hepatology (Baltimore, Md.)|February 15, 2001
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis BR P Perrillo, T Wright, J Rakela, et al.Transfusion|December 2, 2000
Surveillance of HIV-1 genetic subtypesand diversity in the US blood supplyC F de Oliveira, R S Diaz, D M Machado, et al.Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 11, 1998
The influence of hepatitis C virus genotypes on the outcome of liver transplantationH E Vargas, T Laskus, L F Wang, et al.Hepatology (Baltimore, Md.)|March 1, 1997
A prognostic model for the outcome of liver transplantation in patients with cholestatic liver diseaseP Ricci, T M Therneau, M Malinchoc, et al.Pageof 21